The present study has also shown that a long-term inhibition of FLT3-ITD decreased expression of RSK1, but not RSK2 in MV4-11, as well as in primary FLT3-ITD-positive AML cells from one patient we could examine (Figure 3A,G,I). This evidence concerns the gene RPS6KA3 and acute myeloid leukemia.